Xu JF - Search Results

1

Association between age and clinical characteristics and outcomes of COVID-19.

Liu Y, Mao B, Liang S, Yang JW, Lu HW, Chai YH, Wang L, Zhang L, Li QH, Zhao L, He Y, Gu XL, Ji XB, Li L, Jie ZJ, Li Q, Li XY, Lu HZ, Zhang WH, Song YL, Qu JM, Xu JF; Shanghai Clinical Treatment Experts Group for COVID-19. Liu Y, et al. Among authors: xu jf. Eur Respir J. 2020 May 27;55(5):2001112. doi: 10.1183/13993003.01112-2020. Print 2020 May. Eur Respir J. 2020. PMID: 32312864 Free PMC article.

2

[The effect of antioxidant treatment in pneumonia of granulocytopenic rats].

Xu JF, Qu JM, He LX, Zhang J, Li ZZ, Chen XH, Pan J, Li HP. Xu JF, et al. Zhonghua Nei Ke Za Zhi. 2004 Nov;43(11):853-6. Zhonghua Nei Ke Za Zhi. 2004. PMID: 15634548 Chinese.

3

Impaired upregulation of keratinocyte growth factor in injured lungs induced by Pseudomonas aeruginosa in immunosuppressed rats.

Xu JF, Qu JM, He LX, Ou ZL. Xu JF, et al. Chin Med J (Engl). 2006 Sep 5;119(17):1421-9. Chin Med J (Engl). 2006. PMID: 16989742

4

NAC is associated with additional alleviation of lung injury induced by invasive pulmonary aspergillosis in a neutropenic model.

Xu P, Qu JM, Xu JF, Zhang J, Jiang HN, Zhang HJ. Xu P, et al. Among authors: xu jf. Acta Pharmacol Sin. 2009 Jul;30(7):980-6. doi: 10.1038/aps.2009.83. Acta Pharmacol Sin. 2009. PMID: 19575001 Free PMC article.

5

N-Acetylcysteine modulates acute lung injury induced by Pseudomonas aeruginosa in rats.

Xu JF, Qu JM, Li HP. Xu JF, et al. Clin Exp Pharmacol Physiol. 2011 May;38(5):345-51. doi: 10.1111/j.1440-1681.2011.05515.x. Clin Exp Pharmacol Physiol. 2011. PMID: 21401696

6

A therapeutic role for mesenchymal stem cells in acute lung injury independent of hypoxia-induced mitogenic factor.

Song L, Xu J, Qu J, Sai Y, Chen C, Yu L, Li D, Guo X. Song L, et al. J Cell Mol Med. 2012 Feb;16(2):376-85. doi: 10.1111/j.1582-4934.2011.01326.x. J Cell Mol Med. 2012. PMID: 21477220 Free PMC article.

7

Intrapleural delivery of mesenchymal stem cells: a novel potential treatment for pleural diseases.

Qin ZH, Qu JM, Xu JF, Zhang J, Summah H, Sai-Yin HX, Chen CM, Yu L. Qin ZH, et al. Among authors: xu jf. Acta Pharmacol Sin. 2011 May;32(5):581-90. doi: 10.1038/aps.2011.22. Epub 2011 May 2. Acta Pharmacol Sin. 2011. PMID: 21532612 Free PMC article.

8

Novel interventional approaches for ALI/ARDS: cell-based gene therapy.

Zhu YG, Qu JM, Zhang J, Jiang HN, Xu JF. Zhu YG, et al. Among authors: xu jf. Mediators Inflamm. 2011;2011:560194. doi: 10.1155/2011/560194. Epub 2011 Jul 13. Mediators Inflamm. 2011. PMID: 21785528 Free PMC article. Review.

9

Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation.

Xu JF, Washko GR, Nakahira K, Hatabu H, Patel AS, Fernandez IE, Nishino M, Okajima Y, Yamashiro T, Ross JC, Estépar RS, Diaz AA, Li HP, Qu JM, Himes BE, Come CE, D'Aco K, Martinez FJ, Han MK, Lynch DA, Crapo JD, Morse D, Ryter SW, Silverman EK, Rosas IO, Choi AM, Hunninghake GM; COPDGene Investigators. Xu JF, et al. Am J Respir Crit Care Med. 2012 Mar 1;185(5):547-56. doi: 10.1164/rccm.201108-1574OC. Epub 2012 Jan 12. Am J Respir Crit Care Med. 2012. PMID: 22246178 Free PMC article.

10

Clinical analysis of 76 patients pathologically diagnosed with pulmonary cryptococcosis.

Zhang Y, Li N, Zhang Y, Li H, Chen X, Wang S, Zhang X, Zhang R, Xu J, Shi J, Yung RC. Zhang Y, et al. Eur Respir J. 2012 Nov;40(5):1191-200. doi: 10.1183/09031936.00168011. Epub 2012 Mar 9. Eur Respir J. 2012. PMID: 22408204 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

145 results

Search Page